Offerings Archives - Page 8 of 166

1 minute read

Organovo Holdings, Inc. Announces Pricing Of $5.25M Public Offering Of 6,562,500 Shares Of Common Stock And Common Warrants At A Combined Price Of $0.80

May 8, 8:09 PM

Organovo Holdings, Inc. (NASDAQ:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional

ONVO

1 minute read

RxSight Announces $100M Proposed Public Offering Of Common Stock

By Benzinga Newsdesk

May 8, 5:45 PM

RxSight, Inc., (NASDAQ:RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced today that it intends to offer and sell, subject

RXST

1 minute read

Apollomics Announces ~$6M Private Placement Financing; Pursuant To The Terms Of The Subscription Agreements, Co Is Selling An Aggregate Of 19,166,666 Class A Ordinary Shares At A Price Of $0.30/Share

By Benzinga Newsdesk

May 8, 5:28 PM

Apollomics Inc. (NASDAQ:APLM), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it entered into

APLM

1 minute read

Siyata Mobile Announces Pricing Of $4M Public Offering Of Common Shares And Pre-Funded Warrants

By Benzinga Newsdesk

May 8, 9:08 AM

Siyata Mobile Inc. (NASDAQ:SYTA)(NASDAQ:SYTAW) ("Siyata" or the "Company"), a global developer and vendor of Push-to-Talk over Cellular (PoC) handsets and accessories, announces the pricing of its public offering of $4.0

SYTA

2 minute read

Nano-Cap Eledon Pharmaceuticals’ Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence

By Vandana Singh

May 7, 3:40 PM

Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant advancements, reflecting in raised price targets.

ELDN

1 minute read

Alzamend Neuro Halts Equity Offering Program, Prioritizing Shareholder Value Amid Strategic Shift, Shares Slide

By Benzinga Newsdesk

May 7, 2:30 PM

Alzemend Neuro made waves Tuesday when the company announced its decision to terminate its "at-the-market" equity offering program. Shares were down nearly 12% at last check.

ALZN

1 minute read

Alzamend Neuro Announces Termination Of At-The-Market Equity Offering Program

By Benzinga Newsdesk

May 7, 8:20 AM

Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease ("Alzheimer's"), bipolar disorder ("BD"), major

ALZN

2 minute read

ZK International Group Co., Ltd. And The CF Opportunity Fund Closes $5M Financing Priced At $1.59 Per Share

By Benzinga Newsdesk

May 7, 8:15 AM

ZK International Group Co., Ltd. (NASDAQ:ZKIN) ("ZKIN," "ZK International" or the "Company"), a leading provider of advanced steel products, is pleased to announce the successful closing of its previously

ZKIN

1 minute read

Genesis Energy, L.P. Upsizes And Prices Public Offering Of 7.875% Senior Unsecured Notes Due 2032 From $500M To $700M

By Benzinga Newsdesk

May 6, 5:19 PM

Genesis Energy, L.P. (NYSE:GEL) today announced that it has priced a public offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2032 (the "notes"). The offering of the notes was

GEL

1 minute read

GreenPower Announces Proposed Public Offering Of Common Shares & Warrants; No Size Or Amount Disclosed

By Benzinga Newsdesk

May 6, 4:36 PM

GreenPower Motor Company Inc. (NASDAQ:GP) (TSXV:GPV) ("GreenPower" or the "Company"), a leading manufacturer and distributor of purpose-built, all-electric, zero-emission medium and heavy-duty vehicles serving the